In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity

Fájlok

Journal Of Enzyme Inhibition And Medicinal Chemistry. -41 : 1 (2026). -J. Enzym. Inhib. Med. Chem. - 1475-6366

open access article
Szerző